Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by fossi_2002on Sep 28, 2022 10:32am
96 Views
Post# 34992065

RE:RE:RE:RE:RE:Featured profile in Biotecanada

RE:RE:RE:RE:RE:Featured profile in BiotecanadaSo Proph, so far I've always appreciated your analyses and have always been glad for your information.

But what you are writing now is really - to put it positively - more than superficial.

The shareholders just want to be on the same level of information as was discussed long and wide at the publication under discussion.

And there is really no need to spend money on this.

It is clear to me that you are positive for Ceapro in every respect. But if you refuse any critical questioning, then your opinion is unfortunately little relevant for Ceapro interested people who need an objective information.





<< Previous
Bullboard Posts
Next >>